Microsoft: Azure Revenue Set To Reaccelerate In H2 FY2025 Fueled By Strong AI Investments

Summary:

  • Despite strong 1Q FY2025 earnings, Microsoft’s 2Q FY2025 guidance points to a sharp slowdown in total revenue, with Azure growth expected to decelerate further.
  • Its commercial bookings and remaining performance obligations continued to accelerate in 1Q FY2025, supporting strong growth in cloud revenue going forward.
  • While gross margin experienced some contraction, operating margin has remained resilient and is expected to expand further YoY in 2Q, driven by ongoing cost optimization efforts.
  • Management anticipates that Azure growth will reaccelerate in 2H FY2025 as expanded AI infrastructure alleviates demand constraints.
  • Capex as a percentage of total revenue is expected to continue trending higher, anticipating a growth acceleration to 64% YoY in 2Q FY2025, impacting FCF.

Microsoft France headquarters entrance in Issy les Moulineaux near Paris

Jean-Luc Ichard

What Happened

Microsoft’s (NASDAQ:MSFT) stock dropped 6% following its 1Q FY2025 earnings report. The company beat expectations on both revenue and GAAP EPS in 1Q but guided weaker-than-expected Azure growth for 2Q FY2025. MSFT still maintains strong total revenue


Analyst’s Disclosure: I/we have a beneficial long position in the shares of MSFT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *